Back to top
more

MEDIFAST (MED)

(Delayed Data from NYSE)

$18.60 USD

18.60
318,956

-0.23 (-1.22%)

Updated Aug 29, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 251)

Industry: Food - Miscellaneous

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Zacks.com featured highlights include: Magnolia Oil & Gas, Medifast, Textron, ConocoPhillips and Steven Madden

by Zacks Equity Research

Zacks.com featured highlights include: Magnolia Oil & Gas, Medifast, Textron, ConocoPhillips and Steven Madden

Post Holdings (POST) Q3 Earnings Miss Estimates, Sales Up Y/Y

by Zacks Equity Research

Post Holdings (POST) third-quarter performance reflects gains from acquisitions, recovery in foodservice channel as well as strong brand performance across certain categories.

B&G Foods (BGS) Q2 Earnings Miss Estimates, Sales Down Y/Y

by Zacks Equity Research

B&G Foods (BGS) second-quarter fiscal 2021 results reflect lower earnings and sales on unfavorable year-over-year comparisons. Also, input cost inflation affected quarterly results.

5 Top-Performing Liquid Stocks to Snap Up for Higher Returns

by Zacks Equity Research

Here are five top-ranked liquid stocks, Magnolia Oil & Gas (MGY), Medifast (MED), Textron (TXT), ConocoPhillips (COP) and Steven Madden (SHOO), which investors can consider for attractive returns.

TreeHouse Foods (THS) Q2 Earnings Meet Estimates, Stock Down

by Zacks Equity Research

TreeHouse Foods' (THS) second-quarter 2021 results reflect lower earnings and sales. Management curtails 2021 guidance.

Nu Skin (NUS) Q2 Earnings Beat Estimates, Sales Grow Y/Y

by Zacks Equity Research

Nu Skin's (NUS) second-quarter 2021 earnings and revenues increase year over year on growth in sales leaders. Also, management raises 2021 earnings view.

Medifast (MED) Surpasses Q2 Earnings & Revenue Estimates

by Zacks Equity Research

Strength in independent OPTAVIA Coaches along with gross margin expansion and lower SG&A expense rate aids Medifast (MED) in Q2.

Kellogg's (K) Q2 Earnings Top Estimates, Organic Sales View Up

by Zacks Equity Research

Kellogg's (K) second-quarter 2021 results reflect tough comparisons with the year-ago period, though away-from-home channel recovery and emerging market strength were upsides.

Medifast (MED) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Medifast (MED) delivered earnings and revenue surprises of 20.00% and 7.70%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Kraft Heinz (KHC) Q2 Earnings Beat Estimates, Sales Down Y/Y

by Zacks Equity Research

Kraft Heinz's (KHC) second-quarter 2021 sales and earnings decline year over year on softness across United States business.

Here's How Post Holdings (POST) is Placed Before Q3 Earnings

by Zacks Equity Research

Post Holdings' (POST) third-quarter fiscal 2021 results are likely to reflect gains from its prudent buyouts as well as strength across the BellRing Brands segment.

Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "

by Zacks Equity Research

Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.

Everything Worth Noting Ahead of Kellogg's (K) Q2 Earnings

by Zacks Equity Research

Kellogg's (K) second-quarter 2021 results are likely to reflect escalated costs and moderation in at-home consumption-related demand. That said, the company's brand strength has been a driver.

B&G Foods (BGS) Queued for Q2 Earnings: Key Things to Note

by Zacks Equity Research

B&G Foods' (BGS) second-quarter 2021 results are likely to reflect escalated input costs for ingredients, packaging and transportation, though rising online sales have been aiding.

Nu Skin (NUS) Queued for Q2 Earnings: Key Things to Note

by Zacks Equity Research

Nu Skin's (NUS) second-quarter 2021 performance is likely to reflect gains from the company's efforts to strengthen sales leader and expand customer. Also, online strength has been a driver.

Church & Dwight (CHD) Cuts View Despite Q2 Earnings & Sales Beat

by Zacks Equity Research

Church & Dwight's (CHD) second-quarter 2021 results benefit from strong product demand. Management lowers view due to supply-chain woes and cost inflation.

    Medifast (MED) Queued for Q2 Earnings: Key Things to Note

    by Zacks Equity Research

    Medifast's (MED) second-quarter 2021 results are likely to reflect continued strength in OPTAVIA lifestyle solution and coaching support system.

      Kraft Heinz (KHC) Gears Up to Post Q2 Earnings: What in Store?

      by Zacks Equity Research

      Kraft Heinz's (KHC) second-quarter 2021 performance is likely to reflect adverse impacts from escalated cost inflation. Nevertheless, focus on operating model bodes well.

      Service Corporation's (SCI) Q2 Earnings Top Estimates, View Raised

      by Zacks Equity Research

      Service Corporation's (SCI) second-quarter 2021 results reflect solid earnings and sales, on strength in comparable preneed cemetery sales production and comparable preneed funeral sales production.

      Hershey's (HSY) Q2 Earnings Surpass Estimates, Sales Up Y/Y

      by Zacks Equity Research

      Hershey's (HSY) second-quarter 2021 results reflect higher sales and earnings on strength across North America as well as International and Other unit. Management raises 2021 net sales view.

      Pilgrim's Pride (PPC) Q2 Earnings Top Estimates, Sales Up Y/Y

      by Zacks Equity Research

      Pilgrim's Pride's (PPC) second-quarter 2021 results reflect higher sales and earnings on strength across Mexico, the U.K. and Europe as well as the U.S. operations.

      Medifast (MED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

      by Zacks Equity Research

      Medifast (MED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

      Vrishali Bagree headshot

      Mondelez (MDLZ) Q2 Earnings Match Estimates, Revenues Beat

      by Vrishali Bagree

      Mondelez International's (MDLZ) second-quarter 2021 results reflect a rise in earnings and sales. A solid first-half performance led to a raised organic revenue growth view, though high costs are a concern.

      Clorox (CLX) to Report Q4 Earnings: What's in the Cards?

      by Zacks Equity Research

      Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in fourth-quarter fiscal 2021. Nonetheless, its IGNITE strategy and cost-saving initiatives are encouraging.

      Freshpet (FRPT) to Post Q2 Earnings: What Awaits the Stock?

      by Zacks Equity Research

      Freshpet's (FRPT) second-quarter performance is likely to have gained from strong consumption trends. However, rising freight and beef costs are a concern.